Valneva (EPA:VLA) Takes On Some Risk With Its Use Of Debt
Jan 30
French (CAC) Healthcare Sector Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies80
- 7D-0.01%
- 3M2.9%
- 1Y-7.6%
- YTD-0.4%
The Healthcare is pretty flat in the last 7 days, but Sartorius Stedim Biotech has stood out, gaining 5.7%. Unfortunately though, the industry is down 7.6% over the past 12 months. Looking forward, earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | €265.0b | €104.9b | €10.5b | 18.3x | 25.2x | 2.5x |
| Sun, 01 Jan 2023 | €265.5b | €104.9b | €10.5b | 17.6x | 25.3x | 2.5x |
| Tue, 29 Nov 2022 | €268.8b | €105.1b | €10.5b | 17.8x | 25.7x | 2.6x |
| Thu, 27 Oct 2022 | €257.1b | €102.5b | €10.4b | 17.8x | 24.8x | 2.5x |
| Sat, 24 Sep 2022 | €173.6b | €79.3b | €9.0b | 17.1x | 19.3x | 2.2x |
| Mon, 22 Aug 2022 | €193.2b | €78.9b | €9.0b | 20.7x | 21.4x | 2.4x |
| Wed, 20 Jul 2022 | €212.2b | €76.6b | €9.1b | 20.3x | 23.4x | 2.8x |
| Fri, 17 Jun 2022 | €193.4b | €76.4b | €9.2b | 18.1x | 21x | 2.5x |
| Sun, 15 May 2022 | €207.9b | €75.5b | €9.3b | 18.7x | 22.4x | 2.8x |
| Tue, 12 Apr 2022 | €227.5b | €74.4b | €8.8b | 20.3x | 25.9x | 3.1x |
| Thu, 10 Mar 2022 | €203.4b | €73.7b | €8.5b | 19x | 23.9x | 2.8x |
| Sat, 05 Feb 2022 | €207.3b | €71.8b | €8.5b | 18.4x | 24.3x | 2.9x |
| Mon, 03 Jan 2022 | €226.7b | €71.8b | €8.5b | 24.4x | 26.6x | 3.2x |
| Wed, 01 Dec 2021 | €225.6b | €71.8b | €8.5b | 22.1x | 26.5x | 3.1x |
| Fri, 29 Oct 2021 | €221.4b | €70.8b | €8.1b | 23.9x | 27.2x | 3.1x |
| Sun, 26 Sep 2021 | €222.6b | €70.5b | €8.1b | 26.4x | 27.4x | 3.2x |
| Tue, 24 Aug 2021 | €230.1b | €70.2b | €8.1b | 26.1x | 28.4x | 3.3x |
| Wed, 30 Jun 2021 | €212.5b | €70.2b | €8.1b | 26.6x | 26.3x | 3x |
| Sat, 03 Apr 2021 | €199.0b | €68.5b | €14.2b | 28.3x | 14x | 2.9x |
| Tue, 05 Jan 2021 | €185.4b | €67.9b | €14.0b | 28.1x | 13.2x | 2.7x |
| Fri, 09 Oct 2020 | €192.7b | €67.2b | €12.3b | 33.2x | 15.6x | 2.9x |
| Thu, 02 Jul 2020 | €187.8b | €66.3b | €11.7b | 36.2x | 16.1x | 2.8x |
| Sun, 05 Apr 2020 | €160.6b | €66.6b | €4.0b | 28.5x | 40.6x | 2.4x |
Price to Earnings Ratio
52x
Current Industry PE
- Investors are relatively neutral on the French Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 23.8x.
- The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 47% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | 1.14% | |
| Healthcare | -0.012% | |
| Life Sciences | 5.83% | |
| Biotech | 2.27% | |
| Medical Equipment | 1.43% | |
| Healthtech | 1.12% | |
| Pharma | -2.96% | |
| Healthcare Services | -3.94% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 37.9x.
- Analysts are expecting annual earnings growth of 11.0%, which is higher than its past year's earnings growth of 8.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 32% over the next 5 years.
- However this is lower than its past earnings growth rate of 43% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 6.8% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIM Sartorius Stedim Biotech | €346.40 | 5.7% +€1.7b | -10.2% | PE46.9x | |
| EL EssilorLuxottica Société anonyme | €170.75 | 1.7% +€1.3b | -0.7% | PE42.6x | |
| ERF Eurofins Scientific | €68.98 | 6.2% +€773.8m | -23.2% | PE20.7x | |
| EAPI Euroapi | €15.52 | 12.5% +€162.6m | n/a | PE729.3x | |
| VIRP Virbac | €284.00 | 3.3% +€76.1m | -18.5% | PE20.2x |
